Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Serum Institute buys...

    Serum Institute buys polio vaccine co in Czech for 72 million euros

    Written by Ruby Khatun Khatun Published On 2017-04-26T13:12:18+05:30  |  Updated On 26 April 2017 1:12 PM IST
    Serum Institute buys polio vaccine co in Czech for 72 million euros

    Mumbai: Serum Institute of India today acquired the defunct unit in Czech of Florida-based Nanotherapeutics that makes injectable polio doses for 72 million euros.


    The acquisition would catapult the Pune-based company to the largest injectable polio vaccine maker in the world with over 200 million doses, a senior official claimed.


    The plant at Bohumil, which is one hour off the Czech Republic capital Prague, is not functional now and Serum Institute will have to invest an additional 30-40 million euros to make it functional, Serum Institute of India's Chief Executive Officer Adar C Poonawalla told .


    Poonawalla said the company has already paid 45 million euros for the plant and the remaining will be paid one year later.


    Serum Institute is the world's largest vaccine manufacturer by number of doses produced and sold globally.


    "This acquisition will add to our injectable polio capacity by four times to a total of 200 million doses by 2019, making us the largest injectable (not oral) polio vaccine manufacturer in the world," Poonawalla said.


    The current acquisition by the company is the second one overseas since 2012 when it bought a plant in Holland.

    72 million eurosAcquisitionAdar C PoonawallainjectableNanotherapeuticspolio vaccineSerum Institute of India
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok